Oxidative Stress and Carcinogenesis: Potential of Phytochemicals in Breast Cancer Therapy

References

• Jemal A, Bray F, Center MM, Ferlay J, et al.: Global cancer statistics. CA Cancer J Clin 61(2), 69–90, 2011.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, Dikshit R, and Eser S: GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide. IARC Cancer Base No. 11, 2013. International Agency for Research on Cancer, Lyon, France.
   Google Scholar
• Schlebusch CM, Dreyer G, Sluiter MD, Yawitch TM, VandenBerg HJ, et al.: Cancer prevalence in 129 breast-ovarian cancer families tested for BRCA1 and BRCA2 Mutations. SAMJ 100(2), 113–117, 2010.
   PubMed Web of Science ®Google Scholar
• Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, et al.: Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol 36(5), 271–278, 2012.
   PubMed Web of Science ®Google Scholar
• Ekwueme DU, Guy GP Jr, Rim SH, White A, Hall IJ, et al.: Health and economic impact of breast cancer mortality in young women, 1970–2008. Am J Prev Med 46(1), 71–79, 2014.
   PubMed Web of Science ®Google Scholar
• Anderson KN, Schwab RB, and Martinez ME: Reproductive risk factors and breast cancer subtypes: A review of the literature. Breast Cancer Res Treat 144(1), 1–10, 2014.
   PubMed Web of Science ®Google Scholar
• Russo J, Hu YF, Silva ID, and Russo IH: Cancer risk related to mammary gland structure and development. Microsci Res Tech 52(2), 204–223, 2001.
   PubMed Web of Science ®Google Scholar
• Forcados GE, Chinyere CN, and Shu ML: Acalypha wilkesiana: Therapeutic and toxic potential. J Med Surg Pathol 1, 3, 2016.
   Google Scholar
• Alpay M, Backman LR, Cheng X, Dukel M, Kim WJ, et al.: Oxidative stress shapes breast cancer phenotype through chronic activation of ATM-dependent signaling. Breast Cancer Res Treat 151(1), 75–87, 2015.
   PubMed Web of Science ®Google Scholar
• Pisoschi AM and Pop A: The role of antioxidants in the chemistry of oxidative stress: A review. Eur J Med Chem 5(97), 55–74, 2015.
   Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazura M, et al.: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39, 44–84, 2007.
   PubMed Web of Science ®Google Scholar
• Liou G and Storz P: Reactive oxygen species in cancer. Free Radic Res 44(5), 2010.
   PubMed Web of Science ®Google Scholar
• Roque AT, Gambeloni RZ, Felitti S, Ribeiro ML, and Santos JC: Inflammation-induced oxidative stress in breast cancer patients. Med Oncol 32(12), 263, 2015.
   PubMed Web of Science ®Google Scholar
• Yadav N, Kumar S, Marlowe T, Chaudhary AK, Kumar R, et al.: Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents. Cell Death Dis 6(11), 2015.
   PubMed Web of Science ®Google Scholar
• Hill MM, Adrain C, Duriez PJ, Creagh EM, and Martin SJ: Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. Embo J 23, 2134–2145, 2004.
   PubMed Web of Science ®Google Scholar
• Stadtman ER: Role of oxidant species in aging. Curr Med Chem 11, 1105–1112, 2004.
   PubMed Web of Science ®Google Scholar
• Hohn A, Jung T, and Grune T: Pathophysiological importance of aggregated damaged proteins. Free Radic Biol Med 71, 70–89, 2014.
   PubMed Web of Science ®Google Scholar
• Weber D, Davies MJ, and Grune T: Determination of protein carbonyls in plasma, cell extracts, tissue homogenates, isolated proteins: Focus on sample preparation and derivatization conditions. Redox Biol 5, 367–380, 2015.
   PubMed Web of Science ®Google Scholar
• Schupp N, Schinzel R, Heidland A, and Stopper H: Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors. Ann N Y Acad Sci 1043, 685–695, 2005.
   PubMed Web of Science ®Google Scholar
• Younessi P and Yoonessi A: Advanced glycation end-products and their receptor-mediated roles: Inflammation and oxidative stress. Iran J Med Sci 36(3), 154–166, 2011.
   PubMedGoogle Scholar
• Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, et al.: Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 151, 87–95, 2000.
   PubMed Web of Science ®Google Scholar
• Sova H, Jukkola-Vuorinen A, Puistola U, Kauppila S, Karihtala P: 8-Hydroxydeoxy guanosine: a new potential independent prognostic factor in breast cancer. Br J Cancer 102(6), 1018–1023, 2010.
   PubMed Web of Science ®Google Scholar
• Rivlin N, Brosh R, Oren M, and Rotter V: Mutations in the p53 tumor suppressor gene: Important milestones at the various steps of tumorigenesis. Genes Cancer 2(4), 466–447, 2011.
   PubMedGoogle Scholar
• Birben E, Sahiner UM, Sackesen C, Erzurum S, and Kalayci O: Oxidative stress and antioxidant defense. World Allergy Organ J 5(1), 9–19, 2012.
   PubMedGoogle Scholar
• Jia J, Ye T, Cui P, Hua Q, Zeng H, et al.: AP-1 transcription factor mediates VEGF-induced endothelial cell migration and proliferation. Microvasc Res 105, 103–108, 2016.
   PubMed Web of Science ®Google Scholar
• Hou D, Kai K, Li J, Lin S, Terahara N, et al.: Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure–activity relationship and molecular mechanisms. Carcinogenesis 25(1), 29–36, 2004.
   PubMed Web of Science ®Google Scholar
• Kharman-Biz A, Gao H, Ghiasvand R, Zhao C, Zendehdel K, et al.: Expression of activator protein-1 (AP-1) family members in breast cancer. BMC Cancer 13, 441, 2013.
   PubMed Web of Science ®Google Scholar
• Morgan MJ and Liu Z. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 21(1), 103–115, 2011.
   PubMed Web of Science ®Google Scholar
• Su B and Karin M: Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Imm 8, 402–411, 1996.
   PubMed Web of Science ®Google Scholar
• Zhou J, Ching YQ, and Chn W: Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target. Oncotarget 6(8), 5490–5500, 2015.
   PubMed Web of Science ®Google Scholar
• Morgan MJ and Liu Z: Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 21(1), 103–115, 2011.
   PubMed Web of Science ®Google Scholar
• Benedetti S, Nuvoli B, Catalani S, and Ga R: Reactive oxygen species a double-edged sword for mesothelioma. Oncotarget 6(19), 16848–16865, 2015.
   PubMed Web of Science ®Google Scholar
• Shostak K and Chariot A: NF-κB, stem cells and breast cancer: the links get stronger. Breast Cancer Res 13(4), 214, 2011.
   PubMed Web of Science ®Google Scholar
• Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, et al.: Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Oncogene 30(12):1402–1412, 2011.
   PubMed Web of Science ®Google Scholar
• Zubair A and Frieri M: Role of nuclear factor-кB in breast and colorectal cancer. Curr Allergy Asthma Rep 13(1), 44–49, 2013.
   PubMed Web of Science ®Google Scholar
• Pflaum J, Schlosser S, and Martina MM: p53 family and cellular stress responses in cancer. Front Oncol 4, 285, 2014.
   PubMedGoogle Scholar
• Goh AM, Xue Y, Leushacke M, Li L, Wong JS, et al.: Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice. Oncotarget 6(20), 17968–1798, 2015.
   PubMed Web of Science ®Google Scholar
• Reinhardt HC and Schumacher B: The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet 28(3), 128, 2012.
   PubMed Web of Science ®Google Scholar
• Vijayakumaran R, Tan KH, Miranda PJ, Haupt S, and Haupt Y: Regulation of mutant p53 protein expression. Front Oncol 5, 284, 2015.
   PubMed Web of Science ®Google Scholar
• Muller PAJ and Vousden KH: Mutant p53 in cancer: New functions and therapeutic opportunities. Cancer Cell 25(3), 304–317, 2014.
   PubMed Web of Science ®Google Scholar
• Boutros T, Chevet E, and Metrakos P: Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 60(3), 261–310, 2008.
   PubMed Web of Science ®Google Scholar
• Ramos-Ninos M, Haegens A, Shukla A, and Mossman B: Role of mitogen-activated protein kinases (MAPK) in cell injury and proliferation by environmental particulates. Mol Cell Biochem 234–235, 111–118, 2002.
   PubMed Web of Science ®Google Scholar
• Avivar-Valderas A, Salas E, Bobrovnikova-Marjon E, Diehl JA, Nagi C, et al.: PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol Cell Biol 31(17), 3616–3629, 2011.
   PubMed Web of Science ®Google Scholar
• Avivar-Valderas A, Wen HC, and Aguirre-Ghiso JA: Stress signaling and the shaping of the mammary tissue in development and cancer. Oncogene 33(48), 5483–5490, 2013.
   Web of Science ®Google Scholar
• Kame M, Shouma S, El-Merzebany M, Kilic G, Veenstra T, et al.: Effect of tumour necrosis factor-alpha on estrogen metabolic pathways in breast cancer cells. J Cancer 3, 310–321, 2012.
   PubMed Web of Science ®Google Scholar
• Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, et al.: Effect of single and compound knockouts of estrogen receptors alpha and beta on mouse reproductive phenotypes. Development 127, 4277–4291, 2000.
   PubMed Web of Science ®Google Scholar
• Platet N, Cathiard AM, Gleizes M, and Garcia M: Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol/Hematol 51, 55–67, 2004.
   PubMed Web of Science ®Google Scholar
• Mahalingaiah PK, Ponnusamy L, and Singh KP: Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells. Breast Cancer Res Treat 153(1), 41–56, 2015.
   PubMed Web of Science ®Google Scholar
• Yip CH and Rhodes A: Estrogen and progesterone receptors in breast cancer. Future Oncol 14, 2293–2301, 2014.
   Web of Science ®Google Scholar
• Zhao M and Ramaswamy B: Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer. World J Clin Oncol 5(3), 248–262, 2014.
   PubMedGoogle Scholar
• Osborne CK and Schiff R: Mechanisms of endocrine resistance in breast cancer. Annu Rev Med 62, 233–247, 2011.
   PubMed Web of Science ®Google Scholar
• Francken AB, Schouten PC, Bleiker EMA, Linn SC, and Rutgers EJ: Breast cancer in women at high risk: The role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies. The Breast 22(5), 561–568, 2013.
   PubMed Web of Science ®Google Scholar
• Yi YW, Kang HJ, and Bae I: BRCA1 and oxidative stress. Cancers (Basel) 6(2), 771–795, 2014.
   PubMed Web of Science ®Google Scholar
• Ma Y, Fan S, Hu C, Meng Q, Fuqua SA, et al.: BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha. Mol Endocrinol 24(1), 76–90, 2010.
   PubMed Web of Science ®Google Scholar
• Wang L and Di L: BRCA1 and estrogen/estrogen receptor in breast cancer: Where they interact? Int J Biol Sci 10(5), 566–575, 2014.
   PubMed Web of Science ®Google Scholar
• Yedjou CG, Izevbigie EB, and Tchounwou PB: Vernonia amygdalina-induced growth arrest and apoptosis of breast cancer (MCF-7) cells. Pharmacol Pharmacy 4, 93–99, 2013.
   Google Scholar
• Kunnumakkara AB, Anand P, and Aggarwal BB: Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269(2), 199–225, 2008.
   PubMed Web of Science ®Google Scholar
• Mikaili P, Mojaverrostami S, Moloudizargari M, and Aghajanshakeri S: Pharmacological and therapeutic effects of Mentha Longifolia L. and its main constituent, menthol. Anc Sci Life 33(2), 131–138, 2013.
   PubMedGoogle Scholar
• Farombi EO, Shrotriya S, Na HK, Kim SH, and Surh YJ: Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 46(4), 1279–1287, 2008.
   PubMed Web of Science ®Google Scholar
• Mabeta P and Pepper MS: A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents. Angiogenesis 12, 81–90, 2009.
   PubMed Web of Science ®Google Scholar
• Kim Y and Byzova TV: Oxidative stress in angiogenesis and vascular disease. Blood 123(5), 625–631, 2014.
   PubMed Web of Science ®Google Scholar
• Fox SB, Generali DG, and Harris AL: Breast tumor angiogenesis. Breast Cancer Res 9(6), 216, 2007.
   PubMed Web of Science ®Google Scholar
• Chung AS and Ferrara N: Developmental and pathological angiogenesis. Ann Rev Cell Dev Biol 27, 563–584, 2011.
   PubMed Web of Science ®Google Scholar
• Mabeta P: Decreased secretion of vascular endothelial growth factor is associated with increased apoptosis in vascular tumor derived endothelial cells. J Physiol Pharmacol 64, 473–477, 2013.
   PubMed Web of Science ®Google Scholar
• Mabeta P and Pepper MS: Inhibition of hemangioma development in a syngeneic mouse model correlates with bcl-2 suppression and the inhibition of Akt kinase activity. Angiogenesis 15, 131–139, 2012.
   PubMed Web of Science ®Google Scholar
• Graidist P, Martla M, and Sukpondma Y: Cytotoxic activity of Piper cubeba extract in breast cancer cell lines. Nutrients 7, 2707–2718, 2015.
   PubMed Web of Science ®Google Scholar
• Uy TGC, Licuanan AM, Angeles GED, Bote MLCC, Macauyag EAB, et al.: Anti-cancer effect and mechanism of action of Mikania cordata plant extract on MCF-7 Human breast adenocarcinoma cells. Int J Cancer Res 11(2), 80–92, 2015.
   Google Scholar
• Chaudhary S, Chandrashekar KS, Pai KSR, Setty MM, et al.: Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma. BMC Complement Alter Med 15, 50, 2015.
   PubMed Web of Science ®Google Scholar
• Looi CY, Arya A, Cheah FK, Muharram B, Leong KH, et al.: Induction of apoptosis in human breast cancer cells via caspase pathway by Vernodalin isolated from Centratherum anthelminticum (L.) seeds. PLoS One 8(2), e56643, 2013.
   PubMed Web of Science ®Google Scholar
• Hosseini B, Pasdaran A, Kazemi T, Shanehbandi D, Karami H, et al.: Dichloromethane fractions of Scrophularia oxysepala extract induce apoptosis in MCF-7 human breast cancer cells. Bosn J Basic Med Sci 15(1), 26–32, 2015.
   PubMed Web of Science ®Google Scholar
• Lv Z, Liu X, Zhao W, Dong Q, Li F, et al.: Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. Int J Clin Exp Pathol 7(6), 2818–2824, 2014.
   PubMed Web of Science ®Google Scholar
• Pan L, Chai H, and Kinghorn AD: Discovery of new anticancer agents from higher plants. Front Biosci (Schol Ed) 4, 142–156, 2012.
   PubMedGoogle Scholar
• Shao X, Gao D, Wang Y, Jin F, Wu Q, et al.: Application of metabolomics to investigate the antitumor mechanism of flavopiridol in MCF-7 breast cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci 1025, 40–47, 2016.
   PubMed Web of Science ®Google Scholar
• Takeshima M, Ono M, Higuchi T, Chen C, Hara T, et al.: Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines. Cancer Sci 105(3), 252–257, 2014.
   PubMed Web of Science ®Google Scholar
• Gomez LS, Zancan P, Marcondes MC, Ramos-Santos L, Meyer-Fernandes JR, et al.: Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase. Biochimie 95(6), 1336–1343, 2013.
   PubMed Web of Science ®Google Scholar
• Zancan P, Sola-Penna M, Furtado CM, and Da Silva D: Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol Genet Metab 100, 372–378, 2010.
   PubMed Web of Science ®Google Scholar
• Zihlif M, Afifi F, Abu-Dahab R, Majid AMSA, Somrain H, et al.: The antiangiogenic activities of ethanolic crude extracts of four Salvia species. BMC Complement Alter Med 13, 358, 2013.
   PubMed Web of Science ®Google Scholar
• Lee JS, Shukla S, Kim JA, and Kim M: Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential. PloS One 10(2), e0118552, 2015.
   PubMed Web of Science ®Google Scholar
• Muslim NS, Nassar ZD, Aisha AFA, Shafaei A, Idris N, et al.: Antiangiogenesis and antioxidant activity of ethanol extracts of Pithecellobium jiringa. BMC Complement Alter Med 12, 210, 2012.
   PubMed Web of Science ®Google Scholar
• Farzaei MH, Bahramsoltani R, and Rahimi R: Phytochemicals as adjunctive with conventional anticancer therapies. Curr Pharm Des 2016 May 31. PMID: 27262332
   PubMed Web of Science ®Google Scholar
• Greenlee H, Kwan ML, Kushi LH, Song J, Castillo A, et al.: Antioxidant supplement use after breast cancer diagnosis and mortality in the LACE Cohort. Cancer 118(8), 2048–2058, 2012.
   PubMed Web of Science ®Google Scholar
• Harris HR, Orsini N, and Wolk A: Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cancer 50(7), 1223–1231, 2014.
   PubMed Web of Science ®Google Scholar
• Hussain A, Gheewala TM, Vas AJ, Shah K, Goala P, et al.: Growth inhibitory and adjuvant therapeutic potential of aqueous extract of Triticum aestivum on MCF-7 and HeLa cells. Exp Oncol 36(1), 9–16, 2014.
   PubMedGoogle Scholar